{"id":968577,"date":"2021-11-04T17:00:22","date_gmt":"2021-11-04T21:00:22","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=968577"},"modified":"2021-11-04T17:00:24","modified_gmt":"2021-11-04T21:00:24","slug":"britain-becomes-first-country-to-approve-merck-covid-19-pill","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/britain-becomes-first-country-to-approve-merck-covid-19-pill\/","title":{"rendered":"Britain Becomes First Country To Approve Merck COVID-19 Pill"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"float:left\"><div class=\"counts mashsbcount\">18<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fbritain-becomes-first-country-to-approve-merck-covid-19-pill%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=968577&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p class=\"p1\">On Thursday, Britain authorized the use of an antiviral pill by the company Merck to treat COVID-19.<\/p>\n<p class=\"p1\">As <a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/britain-approves-mercks-oral-covid-19-pill-2021-11-04\/\">reported<\/a> by Reuters:&nbsp;<\/p>\n<p class=\"p1\">Britain\u2019s Medicines and Healthcare products Regulatory Agency (MHRA)&nbsp;<a href=\"https:\/\/www.gov.uk\/government\/news\/first-oral-antiviral-for-covid-19-lagevrio-molnupiravir-approved-by-mhra\">recommended<\/a>&nbsp;the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes, and heart disease.<\/p>\n<p class=\"p1\">\u201cThe pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days,\u201d the Associated Press <a href=\"https:\/\/apnews.com\/article\/coronavirus-pandemic-business-europe-health-pandemics-17905e9505a5ff50f2436b2bcb22f59f\">reported<\/a>.&nbsp;<\/p>\n<p class=\"p1\">The country is the first in the world to approve use of the drug, which could potentially lead to other nations doing the same.&nbsp;<\/p>\n<p class=\"p1\">\u201cToday is a historic day for our country, as the U.K. is now the first country in the world to approve an antiviral that can be taken at home for COVID-19,\u201d said British health secretary Sajid Javid.<\/p>\n<p class=\"p1\">As <a href=\"https:\/\/www.dailywire.com\/news\/merck-asks-fda-for-emergency-use-authorization-for-covid-19-pill-cuts-risk-of-death-or-hospitalization-by-approx-50\">reported<\/a> by The Daily Wire, Merck stated last month that the company, as well as Ridgeback Biotherapeutics, asked for emergency authorization from the U.S. Food and Drug Administration (FDA) for the molnupiravir pill.<\/p>\n<p class=\"p1\">\u201cMerck has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and\/or hospitalization,\u201d Merck announced in a press release. \u201cThe companies are actively working with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months.\u201d&nbsp;<\/p>\n<p class=\"p1\">The Daily Wire noted that the appeal was based on \u201cpositive results from a planned interim analysis\u201d which \u201cevaluated molnupiravir in non-hospitalized adult patients with mild-to-moderate COVID-19 who were at risk for progressing to severe COVID-19 and\/or hospitalization.\u201d Per the interim analysis, \u201cmolnupiravir reduced the risk of hospitalization or death by approximately 50%.\u201d<\/p>\n<p class=\"p1\">The FDA reportedly stated in October that a group of independent specialists would look into the effects and safety of the drug later this month.&nbsp;<\/p>\n<p class=\"p1\">The move by Britain, and the chance that other countries could follow its lead, comes as the Biden administration <a href=\"https:\/\/www.dailywire.com\/news\/biden-administration-releases-statement-on-vaccine-mandate-for-private-sector-workers\">pushes for the federal government to force<\/a> private-sector workers to be vaccinated against COVID-19 or be subject to regular testing.&nbsp;<\/p>\n<p class=\"p1\">As&nbsp;<a href=\"https:\/\/www.nytimes.com\/2021\/11\/04\/business\/biden-vaccine-mandate-osha.html\">reported<\/a> by The New York Times, the Biden administration is requiring that \u201clarge companies<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On Thursday, Britain authorized the use of an antiviral pill by the company Merck to treat COVID-19.As reported by Reuters:\u00a0Britain\u2019s Medicines and Healthcare products Regulatory Agency (MHRA)\u00a0recommended\u00a0the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes, and heart disease.\u201cThe pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days,\u201d the Associated Press reported.\u00a0The country is the first in the world to approve use of the drug, which could potentially lead to other nations doing the same.\u00a0\u201cToday is a historic day for our country, as the U.K. is now the first country in the world to approve an antiviral that can be taken at home for COVID-19,\u201d said British health secretary Sajid Javid.As reported by The Daily Wire, Merck stated last month that the company, as well as Ridgeback Biotherapeutics, asked for emergency authorization from the U.S. Food and Drug Administration (FDA) for the molnupiravir pill.\u201cMerck has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and\/or hospitalization,\u201d Merck announced in a press release. \u201cThe companies are actively working with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months.\u201d\u00a0The Daily Wire noted that the appeal was based on \u201cpositive results from a planned interim analysis\u201d which \u201cevaluated molnupiravir in non-hospitalized adult patients with mild-to-moderate COVID-19 who were at risk for progressing to severe COVID-19 and\/or hospitalization.\u201d Per the interim analysis, \u201cmolnupiravir reduced the risk of hospitalization or death by approximately 50%.\u201dThe FDA reportedly stated in October that a group of independent specialists would look into the effects and safety of the drug later this month.\u00a0The move by Britain, and the chance that other countries could follow its lead, comes as the Biden administration pushes for the federal government to force private-sector workers to be vaccinated against COVID-19 or be subject to regular testing.\u00a0As\u00a0reported by The New York Times, the Biden administration is requiring that \u201clarge companies have until Jan. 4 to ensure that their workforces are fully vaccinated,\u201d adding, \u201cWorkers who refuse to get vaccinated must undergo weekly testing.\u201d\u00a0There are also new requirements for workers in healthcare industries. \u201cAll 17 million workers at health care facilities receiving either Medicare or Medicaid funding must be vaccinated by Jan. 4,\u201d The Times added. \u00a0The Times also noted, \u201cCompanies that fail to comply with the rule may be subject to fines, depending on how frequently they violate it and whether violations are intentional, a White House official said. An\u00a0OSHA penalty is typically $13,653 for every serious violation.\u201d\u00a0On Thursday, The Daily Wire\u00a0filed a lawsuit\u00a0against the federal government over the requirement.\u00a0\u201cThe Dhillon Law Group, Inc. and Alliance Defending Freedom filed the legal challenge on behalf of The Daily Wire in the U.S. Court of Appeals for the 6th Circuit,\u201d The Daily Wire\u00a0noted.\u201cThe Daily Wire will not comply with President Biden\u2019s tyrannical vaccine mandate, and we are suing the Biden Administration to put a stop to their gross overreach,\u201d said Daily Wire Co-Founder and Co-CEO Jeremy Boreing. \u201cPresident Biden, the federal government, social media, and the establishment media have conspired to rob Americans of their freedoms in the name of public health. They have broken faith with the American people through conflicting messaging, false information, and by suppressing data and perspectives with which they disagree.\u201d\u00a0The Daily Wire is one of America\u2019s fastest-growing conservative media companies and counter-cultural outlets for news, opinion, and entertainment. Get inside access to The Daily Wire by becoming a member.<\/p>\n","protected":false},"author":95,"featured_media":2315279,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-968577","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/968577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/95"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=968577"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/968577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2315279"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=968577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=968577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=968577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}